Gene Therapy Using Ultrasound | Epigenetic Editors | $83M Series A for Gamma Delta T Cell Engagers

Huge stories shaping the future of medicine this week. Researchers are using ultrasound to deliver gene therapy, bypassing traditional delivery methods entirely. Epigenetic editors are offering a new way to modify gene expression without cutting DNA. And a company developing gamma delta T cell engagers just closed an $83M Series A, a massive bet on a less explored branch of cancer immunotherapy. Ben and Jeff break down the science behind each story and what it means for the future of biotech. Tune in live Tuesdays and Thursdays at 11AM EST on The Biotech Voyager.